基本信息
浏览量:0
职业迁徙
个人简介
Dr. C. Ola Landgren, is a board-certified hematologist/oncologist who specializes in multiple myeloma, smoldering myeloma, monoclonal gammopathy of undetermined significance, and related plasma cell disorders. His research approaches include detailed genomic characterization of tumor cells and cells in the bone marrow microenvironment, partnered with novel drug development, and advanced methods to rule out minimal residual disease (MRD). Dr. Landgren has developed several novel strategies designed to identify MRD detection post-therapy. He leads the clinical and research operations as well as the development of the Myeloma Program at Sylvester
研究兴趣
论文共 463 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Blood (2023)
引用2浏览0引用
2
0
biorxiv(2023)
Blood cancer discoveryno. 5 (2023): 346-348
引用0浏览0WOS引用
0
0
Nature Communicationsno. 1 (2023): 1-12
Bachisio Ziccheddu, Claudia Giannotta,Mattia D'Agostino, Giuseppe Bertuglia,Elona Saraci,Stefania Oliva,Elisa Genuardi,Marios Papadimitriou,Benjamin Diamond,Paolo Corradini,David Coffey,Ola Landgren,
medRxiv : the preprint server for health sciences (2023)
bioRxiv : the preprint server for biology (2023)
引用0浏览0WOS引用
0
0
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn